BT3 Intrinsic Valuation and Fundamental Analysis - Lineage Cell Therapeutics Inc

L	Lineage Cell Therapeutics Inc XBER:BT3	US
S	Suncor Energy Inc NYSE:SU	CA
N	Neodecortech SpA F:FM2	IT

Intrinsic Value

The intrinsic value for Lineage Cell Therapeutics Inc (BT3) under the Base Case is 1.31 EUR. Compared with the current market price of 1.35 EUR, the stock appears Overvalued by 3% .

DCF Value

€1.54

Multiples-Based Value

€1.08

DCF Value

€1.54

Multiples-Based Value

€1.08

DCF suggests undervaluation, while multiples suggest overvaluation.

Why combine DCF with multiples? What is Intrinsic Value?

BT3 Intrinsic Value

Overvaluation 3%

Intrinsic Value

Price €1.35

L

Bear Case

Base Case

Bull Case

Track Buy Zone

20% below Intrinsic Value €1.05

Get notified when the price drops into your buy zone

Current Price €1.35

Intrinsic Value €1.31

Margin of Safety 20% €1.05

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Lineage Cell Therapeutics Inc.

Explain Valuation